← Records

HOUSE v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

E.D. Pa. · No. 2:26-cv-05662

Full docket on CourtListener ↗

No federal docket timeline hydrated for this case yet (state-court settlements have no RECAP docket).

Our records for this case (1)

MatterTypePractice areaCourtDateValue
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.source ↗
filed by Keller Postman LLC · Judge John F. Murphy · No. 2:26-cv-05662 · 28:1332 Diversity-Product Liability · view case timeline →
Comparable settlements $30M–$725M ▾
Comparables split: Bayhealth found a duty of confidentiality survived MTD, while Integris saw removal rejected but underlying privacy claims left 'unclear'; Clements shows even favorable outcomes require factual development before certification.
Comparable settlements $30M–$725M median $59.50M · n=10
Meta $725M · Google $68M · Google Assistant $68M
Per member (realized): ~$30 median · $29–$30 (n=2)
Comparable verdict: Google LLC $425.70M · Google LLC $425M
Class (from complaint): Massachusetts Laborers' Health & Welfare Fund on behalf of itself and others similarly situated who purchased or paid for Combivent Respimat and/or Spiriva Resp
Key precedent: Doe v. Bayhealth Medical Ctr. — survived MTD on healthcare-provider tracking disclosure, closest fact pattern to pharma website/patient data tracking claims.
Main risk: Dismissal at pleading stage on causation/consent grounds, as seen in Integris Health where state privacy claims remained unresolved and federal hooks failed.
Rough EV model (wide — class size is the big unknown, not a prediction): $1.45M–$30M
Small comparable sample, no confirmed class size or program enrollment data for BI; six parallel filings suggest coordinated litigation that could shift outcome via consolidation or early settlement. · grounded in 6 rulings, 10 settlements, 2 verdicts
FilingPrivacy & WiretapE.D. Pa.2026-08-07$30M–$725M
comparable settlements